The increasing burden and complexity of multi-morbidity and polypharmacy in geriatric HIV patients: a cross sectional study of people aged 65 – 74 years and more than 75 years-Reference-Cited by-同舟云学术

The increasing burden and complexity of multi-morbidity and polypharmacy in geriatric HIV patients: a cross sectional study of people aged 65 – 74 years and more than 75 years

Published:2018-04-20 Issue:1 Volume:18 Page:
ISSN:1471-2318
Container-title:BMC Geriatrics
language:en
Short-container-title:BMC Geriatr

Author:

Guaraldi G.^ORCID,Malagoli A.,Calcagno A.,Mussi C.,Celesia B. M.,Carli F.,Piconi S.,De Socio G. V.,Cattelan A. M.,Orofino G.,Riva A.,Focà E.,Nozza S.,Di Perri G.

Publisher

Springer Science and Business Media LLC

Subject

Geriatrics and Gerontology

Link

http://link.springer.com/content/pdf/10.1186/s12877-018-0789-0.pdf

Reference35 articles.

1. Suzman R, Beard JR, Boerma T, Chatterji S. Health in an ageing world--what do we know? Lancet. 2015;385(9967):484–6.

2. Fortin M, Bravo G, Hudon C, Lapointe L, Almirall J, Dubois MF, Vanasse A. Relationship between multimorbidity and health-related quality of life of patients in primary care. Qual Life Res. 2006;15(1):83–91.

3. Starfield B. Challenges to primary care from co- and multi-morbidity. Prim Health Care Res Dev. 2011;12:1–2. https://doi.org/10.1017/S1463423610000484 .

4. Fortin M, Stewart M, Poitras ME, Almirall J, Maddocks H. A systematic review of prevalence studies on multimorbidity: towar a more uniform methodology. Ann Fam Med. 2012;10(2):142–51.

5. Wolff JL, Starfield B, Anderson G. Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med. 2002;162(20):2269–76.

Cited by 129 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular Risk in HIV Patients: Ageing Analysis of the Involved Genes;Applied Sciences;2024-08-26

2. Immunosenescence and its related comorbidities in older people living with HIV;Infectious Diseases & Immunity;2024-08-21

3. The trend analysis of HIV and other sexually transmitted infections among the elderly aged 50 to 69 years from 1990 to 2030;Journal of Global Health;2024-07-19

4. Polypharmacy, anticholinergic burden and drug–drug interaction assessment in people with four-class-resistant HIV: data from the PRESTIGIO registry;Journal of Antimicrobial Chemotherapy;2024-07-13

5. An update on drug–drug interactions in older adults living with human immunodeficiency virus (HIV);Expert Review of Clinical Pharmacology;2024-06-30